Glen Ian Andrews

This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Merck Patent Gmbh, Pfizer Corporation. Active years: 2020-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Glen Ian Andrews. Retrieved from https://idiyas.com/inventor/glen-ian-andrews

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 (Patent Applications = 2)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 6.9

ph-index = 1

Forward Citations = 6(Granted Patents)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2020-2022

Loading Chart...

2 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11274154 - Dosing regimen of avelumab for the treatment of cancer (2022-03-15),

2. 10869924 - PD-L1 antagonist combination treatments (2020-12-22),

Title: Glen Ian Andrews: Innovator in Cancer Treatment

Introduction

Glen Ian Andrews is a notable inventor based in San Diego, CA. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 2 patents, Andrews has focused on improving therapeutic regimens for cancer patients.

Latest Patents

Andrews' latest patents include a dosing regimen of avelumab for the treatment of cancer. This invention relates to an improved dosing regimen of avelumab, aimed at enhancing its effectiveness in treating cancer. Another significant patent is centered around PD-L1 antagonist combination treatments. This disclosure describes combination therapies that include an antagonist of the Programmed Death Ligand 1 receptor (PD-L1) along with another therapeutic agent, specifically for cancer treatment.

Career Highlights

Throughout his career, Glen Ian Andrews has worked with prominent companies in the pharmaceutical industry. He has been associated with Pfizer Corporation and Merck Patent GmbH, where he contributed to the development of innovative cancer therapies.

Collaborations

Andrews has collaborated with notable professionals in his field, including Satjit Singh Brar and Hua Long. Their combined expertise has likely contributed to the advancements in cancer treatment methodologies.

Conclusion

Glen Ian Andrews stands out as an influential inventor in the realm of cancer treatment, with his patents reflecting a commitment to improving patient outcomes. His work continues to inspire advancements in medical therapies.

Profile summary based on public USPTO records.